An efficacy, safety, and pharmacokinetics/pharmacodynamic relationship study of L-dopa/carbidopa [levodopa/carbidopa] in a novel release formulation in parkinson's disease patients
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Osmotica Pharmaceutical
- 13 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Nov 2007 New trial record.